Sartorius Stedim Biotech SA (PA:DIM) — Market Cap & Net Worth
Market Cap & Net Worth: Sartorius Stedim Biotech SA (DIM)
Sartorius Stedim Biotech SA (PA:DIM) has a market capitalization of $17.54 Billion (€15.00 Billion) as of September 8, 2026. Listed on the PA stock exchange, this France-based company holds position #1462 globally and #33 in its home market, demonstrating a -5.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sartorius Stedim Biotech SA's stock price €186.50 by its total outstanding shares 97280845 (97.28 Million). Also see DIM total asset value for a full breakdown of the balance sheet.
Sartorius Stedim Biotech SA Market Cap History: 2015 to 2026
Sartorius Stedim Biotech SA's market capitalization history from 2015 to 2026. Data shows growth from $6.45 Billion to $21.21 Billion (13.89% CAGR). Also see DIM cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Sartorius Stedim Biotech SA is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Large 60
CACLG
|
$2.66 Trillion | 0.66% | #32 of 60 |
|
CAC All-Tradable
CACT
|
$2.89 Trillion | 0.61% | #33 of 179 |
|
CAC All-Tradable Net Total Return
CACTN
|
$2.89 Trillion | 0.61% | #33 of 179 |
|
CAC All Tradable Gross Total Return
CACTR
|
$2.89 Trillion | 0.61% | #33 of 179 |
|
CAC Next 20
CN20
|
$142.82 Billion | 12.28% | #1 of 20 |
|
CAC Health Care
FRHC
|
$243.81 Billion | 7.19% | #3 of 36 |
Weight: Sartorius Stedim Biotech SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sartorius Stedim Biotech SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sartorius Stedim Biotech SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Sartorius Stedim Biotech SA share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
8.05x
Sartorius Stedim Biotech SA's market cap is 8.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
89.92x
Sartorius Stedim Biotech SA's market cap is 89.92 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.60 Billion | $1.05 Billion | $153.68 Million | 6.28x | 42.96x |
| 2017 | $6.68 Billion | $1.08 Billion | $161.09 Million | 6.18x | 41.50x |
| 2018 | $9.74 Billion | $1.21 Billion | $208.05 Million | 8.04x | 46.84x |
| 2019 | $16.56 Billion | $1.44 Billion | $234.57 Million | 11.50x | 70.60x |
| 2020 | $32.70 Billion | $1.91 Billion | $335.93 Million | 17.12x | 97.35x |
| 2021 | $54.28 Billion | $2.89 Billion | $414.40 Million | 18.80x | 130.98x |
| 2022 | $34.15 Billion | $3.49 Billion | $876.10 Million | 9.78x | 38.98x |
| 2023 | $27.17 Billion | $2.78 Billion | $309.70 Million | 9.79x | 87.72x |
| 2024 | $21.46 Billion | $2.78 Billion | $175.10 Million | 7.72x | 122.57x |
| 2025 | $23.88 Billion | $2.97 Billion | $265.60 Million | 8.05x | 89.92x |
Competitor Companies of DIM by Market Capitalization
Companies near Sartorius Stedim Biotech SA in the global market cap rankings as of September 8, 2026. Review DIM goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Sartorius Stedim Biotech SA by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #184 globally with a market cap of $131.38 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #338 globally with a market cap of $80.42 Billion USD ( €68.79 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #358 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #549 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #184 | Intuitive Surgical Inc | NASDAQ:ISRG | $131.38 Billion | $366.70 |
| #338 | EssilorLuxottica S. A. | PA:EL | $80.42 Billion | €148.55 |
| #358 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €74.00 |
| #549 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Sartorius Stedim Biotech SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Sartorius Stedim Biotech SA's market cap moved from $6.45 Billion to $ 21.21 Billion, with a yearly change of 13.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €21.21 Billion | -11.19% |
| 2025 | €23.88 Billion | +11.29% |
| 2024 | €21.46 Billion | -21.00% |
| 2023 | €27.17 Billion | -20.45% |
| 2022 | €34.15 Billion | -37.08% |
| 2021 | €54.28 Billion | +65.98% |
| 2020 | €32.70 Billion | +97.46% |
| 2019 | €16.56 Billion | +69.96% |
| 2018 | €9.74 Billion | +45.77% |
| 2017 | €6.68 Billion | +1.26% |
| 2016 | €6.60 Billion | +2.41% |
| 2015 | €6.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 8th, 2026 the market cap of Sartorius Stedim Biotech SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.54 Billion USD |
| MoneyControl | $17.54 Billion USD |
| MarketWatch | $17.54 Billion USD |
| marketcap.company | $17.54 Billion USD |
| Reuters | $17.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sartorius Stedim Biotech SA
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more